Regulation of glucagon secretion by glucose: Paracrine, intrinsic or both?

Diabetes, Obesity and Metabolism

Volumn 13, Issue SUPPL. 1, 2011, Pages 95-105

  Walker, J N ^a   Ramracheya, R ^a   Zhang, Q ^a,b   Johnson, P R V ^a   Braun, M ^a,b   Rorsman, P ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Glucagon; Insulin; Paracrine; Type 2 diabetes; cell; cell

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADRENALIN; DIAZOXIDE; GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN; SULFONYLUREA; TOLBUTAMIDE; VOLTAGE DEPENDENT ANION CHANNEL;

DIET RESTRICTION; ELECTRIC ACTIVITY; GLUCAGON RELEASE; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; REVIEW;

EID: 79961189391     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01450.x     Document Type: Review

References (64)

1. Frayn KN. Metabolic Regulation: A Human Perspective, 2nd edn. Oxford: Blackwell Science, 2003.
2. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009; 52: 1003-1012.
3. Dunning BE, Foley JE, Ahren B. Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 2005; 48: 1700-1713.
4. Cryer PE. Glucagon and hyperglycaemia in diabetes. Clin Sci (Lond) 2008; 114: 589-590.
5. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011; 60: 391-397.
6. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
7. Rorsman P, Renstrom E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003; 46: 1029-1045.
8. + efflux from rat islets by cationic amino acids. Biochem J 1982; 208: 301-308.
9. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003; 46: 1297-1312.
10. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007; 28: 84-116.
11. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci USA 2010; 107: 16009-16012.
12. A-receptor chloride channels. Nature 1989; 341: 233-236.
13. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003; 5: 330-335.
14. Hauge-Evans AC, King AJ, Carmignac D et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009; 58: 403-411.
15. Pipeleers DG, Schuit FC, Van Schravendijk CF, Van de Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 1985; 117: 817-823.
16. Olsen HL, Theander S, Bokvist K et al. Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells. Endocrinology 2005; 146: 4861-4870.
17. Franklin I, Gromada J, Gjinovci A, Theander S, Wollheim CB. Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 2005; 54: 1808-1815.
18. Johansson H, Gylfe E, Hellman B. Cyclic AMP raises cytoplasmic calcium in pancreatic alpha 2-cells by mobilizing calcium incorporated in response to glucose. Cell Calcium 1989; 10: 205-211.
19. Shiota C, Rocheleau JV, Shiota M, Piston DW, Magnuson MA. Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor. Am J Physiol Endocrinol Metab 2005; 289: E570-577.
20. Munoz A, Hu M, Hussain K et al. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement. Endocrinology 2005; 146: 5514-5521.
21. -/- mouse alpha-cells. Diabetes 2004; 53: S181-189.
22. Barg S, Galvanovskis J, Gopel SO, Rorsman P, Eliasson L. Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 2000; 49: 1500-1510.
23. Ramracheya R, Ward C, Shigeto M et al. Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets. Diabetes 2010; 59: 2198-2208.
24. Wendt A, Birnir B, Buschard K et al. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 2004; 53: 1038-1045.
25. Bailey SJ, Ravier MA, Rutter GA. Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells. Diabetes 2007; 56: 320-327.
26. Braun M, Ramracheya R, Bengtsson M et al. Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 2010; 59: 1694-1701.
27. Unger RH. The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes 1976; 25: 136-151.
28. Cabrera O, Berman DM, Kenyon NS et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 2006; 103: 2334-2339.
29. Braun M, Ramracheya R, Amisten S et al. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009; 52: 1566-1578.
30. Salehi A, Vieira E, Gylfe E. Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 2006; 55: 2318-2323.
31. Cooperberg BA, Cryer PE. Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans. Diabetes Care 2009; 32: 2275-2280.
32. Michael DJ, Ritzel RA, Haataja L, Chow RH. Pancreatic beta-cells secrete insulin in fast- and slow-release forms. Diabetes 2006; 55: 600-607.
33. 2+ channel-dependent exocytosis. Cell Metab 2010; 11: 543-553.
34. Renstrom E, Ding WG, Bokvist K, Rorsman P. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 1996; 17: 513-522.
35. Gromada J, Hoy M, Buschard K, Salehi A, Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 2001; 535: 519-532.
36. Toyota T, Kakizaki M, Kimura K et al. Islet activating protein (IAP) derived from the culture supernatant fluid of Bordetella pertussis: effect on spontaneous diabetic rats. Diabetologia 1978; 14: 319-323.
37. Aguilar-Bryan L, Bryan J, Nakazaki M. Of mice and men: K(ATP) channels and insulin secretion. Recent Prog Horm Res 2001; 56: 47-68.
38. Shiota C, Larsson O, Shelton KD et al. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 2002; 277: 37176-37183.
39. Rodriguez-Diaz R, Gans I, Ricordi C, Caicedo A, Berggren PO. The human islet innervation is unique. Diabetes 2009; 58: A425.
40. Ashcroft FM. K(ATP) channels and insulin secretion: a key role in health and disease. Biochem Soc Trans 2006; 34: 243-246.
41. Rorsman P, Salehi SA, Abdulkader F, Braun M, MacDonald PE. K(ATP)-channels and glucose-regulated glucagon secretion. Trends Endocrinol Metab 2008; 19: 277-284.
42. 2+-dependent action potentials. J Gen Physiol 1988; 91: 223-242.
43. Yoshimoto Y, Fukuyama Y, Horio Y et al. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel. FEBS Lett 1999; 444: 265-269.
44. 2+ channels. J Gen Physiol 1997; 110: 217-228.
45. Le Marchand SJ, Piston DW. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets. J Biol Chem 2010; 285: 14389-14398.
46. + channel in mouse pancreatic beta-cells. Pflugers Arch 1986; 407: 493-499.
47. + channels. J Physiol 2000; 528: 509-520.
48. MacDonald PE, De Marinis YZ, Ramracheya R et al. A KATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 2007; 5: e143.
49. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005; 54: 1789-1797.
50. Girard CA, Wunderlich FT, Shimomura K et al. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. J Clin Invest 2009; 119: 80-90.
51. Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG. Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell 2000; 100: 645-654.
52. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26: 1902-1912.
53. Anello M, Lupi R, Spampinato D et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 2005; 48: 282-289.
54. Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 2008; 28: 233-251.
55. Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000; 3: 757-758.
56. + channel-dependent pathway in mouse islets and beta-cells. Diabetes 2004; 53: 1765-1772.
57. Bohannon NV, Lorenzi M, Grodsky GM, Karam JH. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects. J Clin Endocrinol Metab 1982; 54: 459-462.
58. Ostergard T, Degn KB, Gall MA et al. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency. J Clin Endocrinol Metab 2004; 89: 297-302.
59. Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002; 51: 958-965.
60. Landstedt-Hallin L, Adamson U, Lins PE. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 3140-3145.
61. Kawamori D, Kurpad AJ, Hu J et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 2009; 9: 350-361.
62. Olofsson CS, Salehi A, Gopel SO, Holm C, Rorsman P. Palmitate stimulation of glucagon secretion in mouse pancreatic alpha-cells results from activation of L-type calcium channels and elevation of cytoplasmic calcium. Diabetes 2004; 53: 2836-2843.
63. Galbo H, Richter EA, Hilsted J et al. Hormonal regulation during prolonged exercise. Ann NY Acad Sci 1977; 301: 72-80.
64. Ramracheya RD, Ward C, Abdulkader F et al. GLP-1 inhibits glucagon secretion from human alpha cells by a direct effect. Diabetologia 2010; 53(Suppl 1): A642.